Axela Biosensors Unveils the dotLab™ System
 16 May 2006: Axela Biosensors, Inc. today announced the successful preview of its new dotLab System at Biosensors 2006, The Ninth World Conference on Biosensors, held in Toronto on May 10-12.
Axela Biosensors Inc.
|
Millipore Corporation to Acquire Serologicals
27 Apr 2006: Millipore Corporation (NYSE: MIL) and Serologicals Corporation (Nasdaq: SERO) have announced that their boards of directors have approved a definitive agreement whereby Millipore will acquire Serologicals in an all cash transaction.
Millipore Corporation
|
ELISA automation with Tecan's Freedom EVOlyzer®
21 Apr 2006: The Institute for Clinical Chemistry and Hematology (IKCH) in St Gallen, Switzerland is using Tecan's new generation of ELISA automation systems, the Freedom EVOlyzer, to reduce the hands-on time of its many and varied ELISA tests.
Tecan
|
Bio-Rad Launches Test for Early Diagnosis of the Dengue Virus
 19 Apr 2006: Bio-Rad Laboratories, Inc., a multinational manufacturer and distributor of life science research and clinical diagnostic products, announced today that it has introduced the Platelia Dengue NS1 Ag assay for dengue screening based on the specific detection of dengue virus NS1 antigen.
Bio-Rad Laboratories Informatics Division
|
Bio-Rad Launches New Anti-tTG Assays for Celiac Disease
 18 Apr 2006: Bio-Rad Laboratories, Inc., a multinational manufacturer and distributor of clinical diagnostics products and leader in autoimmune testing, announced today the launch of anti-tissue transglutaminase (tTG) assay IgA and IgG assays for celiac disease. The new assays are FDA-cleared, CE-marked and automation-ready.
Bio-Rad Laboratories Informatics Division
|
ABLYNX AND PROCTER & GAMBLE EXTEND NANOBODY™ DRUG DISCOVERY AND DEVELOPMENT AGREEMENT TO METABOLIC TARGETS
11 Apr 2006: Ablynx has announced that its drug discovery and development alliance with Procter & Gamble Pharmaceuticals, Inc. a subsidiary of The Procter & Gamble Company has been extended to include metabolic disease targets.
Ablynx
|
First antibody reagents pre-tested and optimised for cytometry...
 11 Apr 2006: Guava Technologies, Inc. has announced the introduction of Express Cell Surface Antibodies, a new line of antibody reagents designed to identify subsets of hematopoetic-derived cells by their patterns of protein expression.
Guava Technologies
|
Biomethodes initiates new projects based on Solexis®
11 Apr 2006: Biomethodes has announced the beginning of new projects based on its proprietary technology Solexis®.
Biométhodes
|
"The Antibody Trilogy"
11 Apr 2006: Problems with humanization, folding, expression levels, immunogenicity and cost continue to plague the field. Don't miss this opportunity to attend a Trilogy of meetings devoted to the
expression of difficult proteins.
Cambridge Healthtech Institute
|
BD Biosciences, Pharmingen and Bioimaging Systems, Announce the Availability of High-Content Bioimaging Certified Reagents
06 Apr 2006: BD Biosciences has launched a collection of antibody reagents that have been tested and certified for their utility in automated bioimaging (high content), and microscopy applications.
BD Biosciences
|
Screening Unit Use Tecan's Freedom EVO® for Molecular Pharmacology 
